1868 results about "Methyl palmoxirate" patented technology

The present application relates to a kind of equipment and method for preparing hexamethylene diisocyanate by hexamethylene diaminoformate intermediate pyrolysis, the present application uses continuous pyrolysis reaction device, HDI can be prepared in high-boiling solvent, can completely replace the existing phosgene and phosgene derivative method for preparing HDI, solve the safety and pollution problem of phosgene method;Compared with low-boiling solvent process, the present application can greatly reduce energy consumption in product separation stage, and the energy consumption required for separating solvent in high-boiling solvent method is 1 / 10 of low-boiling solvent process, it is a green environmental protection energy-saving process;The present application uses non-toxic high-boiling solvent, compared with low-boiling solvent method, production safety is guaranteed;Compared with ordinary high-boiling solvent, the present application can avoid multiple contact between isocyanate and alcohol, and the yield of HDI can be further improved;The process flow of the present application is simple, and the operating condition is mild, it is a process that can be rapidly industrialized.

The present application relates to the field of microbiological technology, and particularly relates to a pathogenic bacterium causing root rot symptoms of red heart disease of Astragalus membranaceus and application thereof, the pathogenic bacterium is Fusarium sp. Fusarium sp. FUS-001-2025, preserved in China General Microbiological Culture Collection Center on March 16, 2026, with the preservation number of CGMCC No. 42529; it is determined to be a new recorded strain of Fusarium sp. through morphological and molecular identification, and the bactericide sensitivity determination shows that 25% silthiofam·prochloraz has the strongest inhibition effect, 25% bromothalonil, 50% azoxystrobin and 70% methylthiophanate have significant inhibition at high concentrations. The present application provides an important pathogenic bacterium resource for the pathogenic mechanism, disease resistance evaluation and development of control agents of red heart disease of Astragalus membranaceus.

This invention discloses a method for synthesizing a venetum intermediate, specifically as follows: Step 1: In an organic solvent, 2,4-difluorobenzoic acid and 5-hydroxy-7-azaindole undergo an etherification reaction under the action of an acid-binding agent. After the reaction, post-treatment yields 2-((1h-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoic acid; Step 2: 2-((1h-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoic acid reacts with 1-((2-(4-chlorophenyl)-4,4-dimethylcyclohexene-1-)methyl)piperazine in… An amination reaction occurs under the action of a base. After the reaction, post-treatment yields 2-(7-azaindole-5-oxy)-4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohexene-1-)methyl)piperazine-1-)benzoic acid, i.e., Venetantora intermediate III. The synthetic process provided by this invention avoids Grignard reactions and subsequent hydrolysis reactions, shortens the operation steps, simplifies the synthetic process, and provides a simple and easy-to-operate synthetic process. The raw materials are inexpensive and readily available, while avoiding the use of highly toxic raw materials. The production process is green and environmentally friendly, and suitable for industrial production.

To provide compounds having ant behavior inhibitory activity, and repellents and pest control agents containing the same. [Solution] An ant behavior inhibitor characterized by containing at least one compound selected from the group consisting of indole, methylheptenone, and methyl dihydrojasmonate.

The application discloses a pinacine alkyl tetrahydrocarbazole fluorescent probe capable of detecting cell lysosome polarity and a preparation method and application thereof. 9-(3-(dimethylamino)propyl)-3,3-dimethyl-2,3,4,9-tetrahydro-1H-2,4-bridged methylene carbazole-6-formaldehyde is used as raw material, and condensation reaction is carried out with 1,3-indan dione to obtain compound 2-(2-(9-(3-(dimethylamino)propyl)-3,3-dimethyl-2,3,4,9-tetrahydro-1H-2,4-bridged methylene carbazole-6-yl)vinyl)-1-indene-1,3(2H)-dione (TC-AP-ID), and the probe can specifically detect the polarity of cell lysosomes. In a mixed system of 1,4-dioxane and water, with the increase of the polarity of the system, the fluorescence color of the probe gradually changes from orange to red, and the fluorescence intensity significantly decreases. The probe has the advantages of simple synthesis, good selectivity, high sensitivity, good biocompatibility, low toxicity and the like, can be applied to targeted detection of the polarity of cell lysosomes, and has a good application prospect.

The invention relates to a porous metal-organic network (MOF) comprising metal ions coordinated to an organic ligand, wherein at least 66% of the metal ions are iron(III) ions and the organic ligand is 5,5'-methylenediisophthalic acid, its preparation process, and its use for releasing a substance in a controlled manner. The present invention also relates to pharmaceutical compositions comprising such a metal-organic network.

The present application relates to a kind of phenol and methanol directly prepared (methyl) anisole mode, the method includes the following steps: under the action of composite catalyst, phenol and methanol are catalytically generated methyl anisole, the composite catalyst is Ho / β molecular sieve catalyst and Ti / UiO-66 with mass ratio Ho / β:Ti / UiO-66 0.3-0.6:1 Mixed composite catalyst.The process reaction step is simple, and synthesis is realized in one step, and the total selectivity of methyl anisole is as high as 76% or more, and can be continuously and stably operated for 3000h.

This invention discloses a cationic etherifying agent and its preparation method, belonging to the field of cationic etherifying agent production technology. The preparation method includes: continuously feeding trimethylamine and hydrochloric acid into a raw material pretreatment unit, pre-cooling to -10~20℃; entering a first tubular reactor, reacting at -10℃~20℃ and 0.15MPa for 10~60 minutes to generate trimethylammonium chloride; trimethylammonium chloride and epichlorohydrin entering a static mixer, simultaneously adding a catalyst and an organic amine; entering a second tubular reactor, reacting at 10~50℃ and 0.2MPa for 1~3 hours; during the reaction, monitoring the chloride ion concentration and epichlorohydrin residue in real time, dynamically adjusting the reaction parameters; filtering the reaction product through a nanofiltration membrane to obtain a high-purity cationic etherifying agent. This invention employs a continuous tubular reaction process combined with automatic control and nanofiltration membrane separation, resulting in a short production cycle, low energy consumption, few by-products, and a high-purity, odorless product, showing good industrial application prospects.

The application relates to the technical field of high polymer materials, in particular to ammonia-removing and humidity-controlling water gel as well as a preparation method and application thereof, which comprises the following raw materials: deionized water, AM, MBA, Gly, lithium chloride, 2-hydroxy-2-methyl propiophenone, magnesium chloride or magnesium oxide; the AM and the MBA are added into the deionized water, and polymerization is initiated by 2-hydroxy-2-methyl propiophenone and ultraviolet light to form a polyacrylamide network, so that the novel water gel can stably control humidity and effectively remove ammonia in long-term storage, effectively adsorb ammonia and provide molecular-level water molecules, and the required humidity of a cigar is maintained; secondly, the MBA is added into the water gel to form a more stable and porous three-dimensional crosslinking network, which can not only adjust the moisture absorption / relaxation rate of the water gel, realize humidity buffering, but also adsorb ammonia molecules through acid-base neutralization, ion exchange, hydrogen bonding, electrostatic interaction, so that the water gel can maintain the required humidity of the cigar for a long time and reduce the volatilization of ammonia.

The present application relates to a kind of preparation method of trifluoromethyl pyrazole compound, belong to the technical field of organic synthesis.The specific method is: (1) trifluoroacetyl ethyl acetate is first with hydrazine hydrate cyclization reaction and generates compound of formula III;(2) under the catalysis of base, compound of formula III is reacted with difluoromethylation reagent and generates compound of formula II;(3) compound of formula II is reacted with methylating agent and obtains compound of formula I;The difluoromethylation reagent is difluoro-monochloromethane or sodium difluoro-monochloroacetate;The methylating agent is chloromethane, bromomethane, iodomethane, dimethyl sulfate or dimethyl carbonate.The present application is prepared by changing reaction route, and the higher-priced raw material methylhydrazine is replaced, and isomer impurity is no longer generated in the product prepared.Not only raw material cost is reduced, but also the purity of product is improved.

[Problem] To provide a means capable of more efficiently exerting an antibacterial effect against bacteria. [Solution] An antibacterial agent containing at least two compounds selected from the group consisting of trans-2-methyl-2-pentenal, 2-methylbutanal, trans-2-hexenal, propionaldehyde, 3-methylpentanol, and 2,5-dimethylfuran.

This invention relates to a compound containing trifluoromethyloxadiazole and a spirocyclic structure, or a pesticide-acceptable salt, hydrate, or solvate thereof, characterized in that the structure of the compound containing trifluoromethyloxadiazole and a spirocyclic structure is shown in general formula I. Compared with the prior art, the compound provided by this invention can be used to prepare histone deacetylase inhibitors, effectively inhibiting the growth and reproduction of various rust fungal spores, with effects comparable to fluopyram.

An aerosol generating material for use in an aerosol delivery device is provided, the aerosol generating material including a fibrous plant material, an aerosol former, and an active agent including at least a substituted 3-(1-methylpyrrolidin-2-yl)pyridine, a 3-(azetidin-2- yl)pyridine, or a 3-(azetidin-2-ylmethoxy)pyridine. The active agent is absorbed or adsorbed in or on the fibrous plant material. The disclosure further provides devices and aerosol provision systems incorporating such aerosol generating material.

The present disclosure relates to solid state forms of Compound (1) freebase. The present disclosure also relates to processes for the preparation of the solid state forms, the pharmaceutical compositions comprising the forms, and the use thereof, e.g., in the treatment and prevention of disorders in which NLRP3 activity is implicated.

The application belongs to the field of medicine synthesis, and particularly relates to a preparation method of mesopram racemate. First, 1-(4-methoxy-3-propoxyphenyl) ethan-1-one, methyl triphenylphosphonium bromide and alkali are reacted in a solvent under inert gas protection to obtain a styrene intermediate I; then the intermediate I, a BocNCl2 reagent and an alkali reagent are reacted in a solvent to generate the mesopram racemate. The method provided by the application has the advantages of short steps, low cost, no metal residue and mild reaction conditions, and is suitable for industrial production.

The application relates to the technical field of organic synthesis, and discloses a synthesis method of benzthiazuron, which comprises the following steps: step 1, addition reaction of alpha-methyl styrene and hydrogen chloride gas, and degassing to obtain a first reaction liquid; step 2, substitution reaction of the first reaction liquid and cyanate in the presence of a zinc chloride catalyst, and filtration to obtain a second reaction liquid containing isocyanate; and step 3, construction of an inorganic salt aqueous solution system with a density of 1.05-1.10 g / ml and a pH of 9-10, dropwise addition of the second reaction liquid into the system for condensation reaction with o-chlorobenzylamine, and post-treatment and refinement to obtain a target product. The non-phosgene route of chloro-isocyanate substitution is adopted, and the use of the toxic phosgene is completely avoided; the salting-out effect and interface control generated by the specific high-density salt solution effectively inhibit the isocyanate hydrolysis side reaction, and the reaction yield and product purity are obviously improved.

The invention is directed to a crosslinkable polyethylene composition comprising an additive composition consisting of polyethylene glycol and a mixture of 4,4′-thiobis (2-tertbutyl-5-methylphenol) plus thiodiethylene bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate].

Provided herein are methods for preparing crystalline forms of (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate.

The application discloses a multifunctional biomaterial with light protection and repair functions, which comprises the following components in percentage by mass: 4-8% of methacrylated gelatin, 0.5-2% of nanomicelles of ferulic acid, 0.5-1% of adhesive peptides, 0.5-1.5% of hyaluronic acid and 0.5-1% of ekdromicin. The application further discloses a preparation method of the multifunctional biomaterial and application thereof. The multifunctional biomaterial realizes a trinity synergistic effect of 'protection-repair-regeneration', target enrichment of active ingredients to damaged parts, and can stimulate vascular regeneration, improve skin microcirculation, has antioxidant, anti-inflammatory and healing functions, and promotes repair of light-damaged skin.

The present invention relates to the technical field of organic synthesis. Provided is a method for preparing 2,6-bis(4-azidobenzylidene)-4-methylcyclohexanone, comprising the following steps: S1, subjecting 4-nitrobenzaldehyde and trimethylsilyl azide to a nucleophilic aromatic substitution reaction to obtain 4-azidobenzaldehyde; S2, subjecting 4-azidobenzaldehyde and 4-methylcyclohexanone to an aldol condensation reaction, so as to obtain 2,6-bis(4-azidobenzylidene)-4-methylcyclohexanone. The described technical solution addresses the problems in the related art where the process for synthesizing 2,6-bis(4-azidobenzylidene)-4-methylcyclohexanone has low product yield, high costs and high energy consumption, and is not conducive to large-scale industrial production.

This invention discloses a method for resolving isomers of methylfenacin ester, comprising: firstly, dissolving methylfenacin ester in a first solvent and adding L-tartaric acid, dissolving until clear; then adjusting the system temperature to 40℃-53℃ and adding L-tartaric acid seed crystals of the target isomer; subsequently, cooling the system to 20℃-30℃, filtering the precipitated product, and obtaining the L-tartaric acid seed crystals of the target isomer as the filter cake; dissociating the L-tartaric acid seed crystals of the target isomer using an alkaline resin, collecting the filtrate, and drying the filtrate to obtain the target isomer of methylfenacin ester. This invention achieves the resolution of isomers of methylfenacin ester by using L-tartaric acid, and through optimization of conditions, achieves a yield of not less than 74.1% and an ee of 91.1% for the target isomer of methylfenacin ester. The resolution method provided by this invention is simple to operate, easy to control, suitable for large-scale production, and meets industrial needs.

The invention discloses a dope solution for membrane fabrication comprising a blend of TEP with NMP as a solvent system in a process to make PVDF membranes, where PVDF resin comprises a homopolymer resin, or a copolymer of VDF and at least one of hexafluoroprdpylene, trifluoroethylene, chlorotrifluoroethylene, or a tetrafluoropropene.

The present invention relates to a novel crystalline form of a helicase-primase inhibitor compound, and to pharmaceutical compositions comprising the novel crystalline form, to methods of production of the novel crystalline form, to the crystalline form in medicine and for use in the treatment of herpes viral infections.

The invention provides a preparation method of an antistatic metallocene catalyst. The method comprises the following steps: carrying out thermal activation treatment on a silica gel carrier; loading alkyl tin chloride on the silica gel carrier to obtain an alkyl tin chloride modified silica gel carrier; adding methylaluminoxane into the alkyl tin chloride modified silica gel carrier to obtain a methylaluminoxane / alkyl tin chloride modified silica gel carrier; adding a metallocene compound into the methylaluminoxane / alkyl tin chloride modified silica gel carrier for heating reaction, and then adding an antistatic agent to obtain the antistatic metallocene catalyst. Alkyl tin chloride is used for modifying a silica gel carrier and reacts with hydroxyl to greatly eliminate the hydroxyl; the loading capacity can be improved by combining with MAO, and metallocene combination sites can be increased; after the antistatic agent is added, static electricity generated in the reaction process is reduced, the flaking phenomenon is reduced, and the static electricity range can be controlled to be + / -0.02 KV.

The application discloses MS glue, an MS glue additive and a preparation method of the MS glue additive, and the preparation method of the MS glue additive comprises the following steps: dissolving pentamethyl piperidyl alcohol in an organic solvent, heating, and stirring; adding octadecadiene acid dimer, and stirring; adding diisopropyl bis(dioctyl pyrophosphoric acyloxy) titanate, and stirring; heating, and extracting the solvent under reduced pressure to obtain a product. In the technical scheme, the MS glue additive can effectively capture free radicals in a polymer degradation chain reaction, thereby inhibiting a photo-oxidation process, and achieving a light stabilization purpose. Through evaluation, the additive can greatly reduce performance attenuation and yellowing of the MS glue under light aging.

This invention discloses a polysubstituted indole[1,2-a]quinoxaline compound, its preparation method, and its applications. The structural formula of the polysubstituted indole[1,2-a]quinoxaline compound of this invention is or , where R 1 Selected from -H or -F, R 2 The compounds are selected from phenyl, 4-methylphenyl, 4-methoxyphenyl, or 4-fluorophenyl. The polysubstituted indole[1,2-a]quinoxaline compounds of this invention have novel structures and significant antitumor activity, making them suitable for the synthesis of anticancer drugs. Furthermore, their preparation methods offer advantages such as readily available and inexpensive catalysts, broad substrate applicability, good functional group tolerance, simple operation, mild reaction conditions, and high step economy, making them suitable for large-scale industrial production and application.